However, if you are very sensitive, even a short bout of medication-induced diarrhoea might trigger your IBS to act up (for example, causing a cascade of colon contractions)
According to Qsymias label, its approved for chronic weight management in: Adults and pediatric patients aged 12 years and older with obesity Adults who are overweight with at least one weight-related comorbid condition, such as high blood pressure or high cholesterol Some healthcare providers might prescribe Qsymia outside of those parameters, and in these cases, insurance companies may decline coverage
Other considerations include individuals with gastrointestinal issues, as semaglutide may cause nausea, vomiting, or diarrhea, especially during the initial stages of treatment
As of 2026, retatrutide remains investigational and is only available through clinical trials